FuelCell Energy to install and operate a 5.6 MW fuel cell system to supply ultra-clean electricity and steam to Pfizer's R&D facility in Groton, Connecticut under a power purchase agreement (PPA).
FuelCell Energy, Inc., a US-based developer, manufacturer and operator of fuel cell power plants has announced plans for the installation of a 5.6 MW fuel cell combined heat and power (CHP) system for Pfizer Inc., one of the world’s largest biopharmaceutical companies, for its R&D facility in Groton, Connecticut. Pfizer will purchase the heat, as steam, and power under a 20 year power purchase agreement (PPA).
Two 2.8 MW CHP units in tandem
The CHP-configured fuel cell system will include two DFC3000 fuel cell power plants, each rated at 2.8 MW that operate in tandem, to produce power and heat via an electrochemical process supplying a portion of the Groton facility’s energy needs. The fuel cell are of carbonate type and are fuel flexible, capable of operating on natural gas or biogas. They will operate parallel with the electric grid and, in the event of a grid disturbance, continue to provide power to Pfizer’s Groton facility by switching to grid independent ‘island’ mode. The fuel cell installation is expected to be fully operational by summer 2016.
– This power purchase model delivers immediate value while increasing electrical reliability by providing the security of on-site power with a financial structure that avoids an investment in power generation assets. FuelCell Energy installs, operates and maintains the fuel cell power plants affordably addressing both energy and sustainability goals, said Chip Bottone, President and Chief Executive Officer, FuelCell Energy, Inc.
5113/AS
